The next few years are going to see an extensive use of artificial intelligence and machine learning algorithms in healthcare. Despite investment strategies and technological foundations developed, concerns are being raised on the ethical and responsible use of AI.
As the debate about the concern continued, the executive vice president and chief technology officer for Royal Philips, Henk van Houten clarified his position, and suggested a list of five guiding principles for the design and responsible use of AI in healthcare and personal health applications.
According to Hank, the five principles should emphasize on well-being, oversight, robustness, fairness, and transparency. The core value of AI-enabled solutions must be set for the welfare of customers, patients, and society at large.
The development and validation of AI, according to Hank, must accurately feature the diversity of people in the targeted group. Before a different target group is chosen for application of AI, it has to be revalidated and possibly retrained first, says Hank
Amongst the many AI-enabled solutions offered by Philips, VitalEye has been developed for automated breathing detection for varied range of patient sizes, it requires no accessories or manual adjustments. Other than that, they have also developed IntelliSpace, a comprehensive advanced data integration, visualization, and analysis platform that enhances diagnostic confidence.
An Enhanced Remote Patient Monitoring in 2020
Remote patient monitoring technologies have been steadily growing, especially for the benefit of the older population. But for a broader adoption of RPM in 2020, simplification of technologies, such as bluetooth will be the key.
As part of a transition to a value based care model, over 88 percent of hospitals and health systems have invested in remote patient monitoring technologies, according to a 2019 Spyglass Consulting report.
In combination with telehealth video conferencing and healthcare wearables, mobile technologies will have a significant role for remote patient monitoring, alongside deployment of electronic health record-based patient portals.
As Harry Soza, CEO of CAREMIN Dr, Silicon Valley tech company stated, he sees great potential for significant growth in 2020 for advanced population health management through RPM. The company according to Soza, has clients that have embarked on large scale expansion of their RPM programs, after having experimented on smaller pilots during 2019.
According to Soza, any RPM expansion will require specialised monitoring systems, because this process differs fundamentally from traditional methods of interaction between providers and patients.
There are many barriers that are hindering the expansion of RPM programs, according to Soza, who feels that business management has to be blended with new technology, only then adoption will be rapid, and implementation will be easy for provider groups. This according to Soza is the largest challenge confronting the RPM industry today.
